Unmet Medical Needs in Chronic, Non-Communicable Inflammatory Skin Diseases

    June 2022 in “ Frontiers in medicine ”
    Hideyuki Ujiie, David Rosmarin, Michael P. Schön … Ralf J. Ludwig
    Studysummary This review discusses the complex causes and treatment challenges of chronic inflammatory skin diseases, emphasizing the need for biomarkers to predict treatment responses; it reports no new clinical results.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on frontiersin.org →
    Discuss this study in the Community →

    Research cited in this study 21

    1. Efficacy and Safety of the Oral Janus Kinase Inhibitor Baricitinib in the Treatment of Adults with Alopecia Areata: Phase 2 Results from a Randomized Controlled Study Journal of The American Academy of Dermatology · 2021
    2. Updates and new medical treatments for vitiligo (Review) Experimental and Therapeutic Medicine · 2021
    3. Features Associated With Quality of Life Impairment in Hidradenitis Suppurativa Patients Frontiers in Medicine · 2021
    4. A Phase 2a Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of the Oral Janus Kinase Inhibitors Ritlecitinib and Brepocitinib in Alopecia Areata: 24-Week Results Journal of the American Academy of Dermatology · 2021
    5. Italian Guidelines in Diagnosis and Treatment of Alopecia Areata Giornale italiano di dermatologia e venereologia · 2019
    6. A Review of Cutaneous Lupus Erythematosus: Improving Outcomes with a Multidisciplinary Approach Journal of Multidisciplinary Healthcare · 2019
    7. An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis Journal of Investigative Dermatology · 2018
    8. Nail Changes in Alopecia Areata: An Update and Review International Journal of Dermatology · 2018
    9. Oral Ruxolitinib Induces Hair Regrowth in Patients with Moderate-to-Severe Alopecia Areata JCI insight · 2016
    10. Familial Aggregation of Alopecia Areata Journal of the American Academy of Dermatology · 2016
    11. Alopecia Areata Is Driven by Cytotoxic T Lymphocytes and Is Reversed by JAK Inhibition Nature medicine · 2014
    12. Guidelines for the Management of Vitiligo: The European Dermatology Forum Consensus British Journal of Dermatology · 2013
    13. Histopathology of Alopecia Areata, Acute and Chronic: Why Is It Important to the Clinician? Dermatologic Therapy · 2011
    14. Quality of Life in Cutaneous Lupus Erythematosus Journal of the American Academy of Dermatology · 2011
    15. Intralesional Steroids for Alopecia Areata International Journal of Trichology · 2010
    16. Medium-Dose Prednisolone Pulse Therapy in Alopecia Areata Dermato-endocrinology · 2009
    17. Placebo-Controlled Oral Pulse Prednisolone Therapy in Alopecia Areata Journal of the American Academy of Dermatology · 2005
    18. Guidelines for the Management of Alopecia Areata British Journal of Dermatology · 2003
    19. Efficacy of Topical Sensitizers in the Treatment of Alopecia Areata Journal of the American Academy of Dermatology · 1998
    20. Pulsed Administration of Corticosteroids in the Treatment of Alopecia Areata International Journal of Dermatology · 1996
    21. Vitiligo Complicating Diphencyprone Sensitization Therapy for Alopecia Universalis British Journal of Dermatology · 1995

    Related research 1

    1. Serum Zinc Concentration in Patients With Alopecia Areata Acta dermato-venereologica (Print) · 2023